Dr. Stephen E. Wolverton, MD

Expert Publications

• Monitoring for adverse effects from systemic drugs used in dermatology.
• Pemphigus foliaceus with epidermal detachment: adverse events from patch testing.
• Suggested guidelines for patient monitoring: hepatic and hematologic toxicity attributable to systemic dermatologic drugs.
• The efficacy and safety of rituximab in refractory pemphigus: a review of case reports.
• Optimizing clinical use of azathioprine with newer pharmacogenetic data.
• Controversies in dermatologic drug therapy.
• Can short courses of systemic corticosteroids truly cause osteonecrosis?
• Moxifloxacin-induced drug hypersensitivity syndrome with features of toxic epidermal necrolysis.
• Systemic drug therapy for psoriasis. The most critical issues.
• Recent trends in systemic psoriasis treatment costs.
• Immunosuppression and sebaceous tumors: a confirmed diagnosis of Muir-Torre syndrome unmasked by immunosuppressive therapy.
• Top-accessed article: topical rapamycin.
• Drug hypersensitivity syndrome in a patient receiving vismodegib.
• Practice Gaps: Drug Reactions.
• Medical Malpractice in Dermatology-Part I: Reducing the Risks of a Lawsuit.

Media Releases

Get to know Dermatologist Dr. Stephen E. Wolverton, who serves the population of Indianapolis, Indiana.

Stephen E. Wolverton, MD is a dermatologist currently practicing with Indiana University Health. Indiana University Health is the largest network of physicians in the state of Indiana. A unique partnership with Indiana University School of Medicine, one of the nation’s leading medical schools, gives patients access to leading-edge medicine and treatment options that are available first, and often only, at IU Health.

After receiving his undergraduate degree at Ball State University in 1975, Dr. Wolverton attended medical school at Indiana University School of Medicine and received his MD degree in 1979.  Dr. Wolverton initially pursued a career in Family Practice, completing his residency at St. Elizabeth Medical Center in Dayton, Ohio in 1982. This residency was followed by a year in a junior faculty position at the same FP residency program.

Dr. Wolverton initiated his Dermatology career completing his residency at Wright State University in Dayton, Ohio, from 1983 to 1985. Subsequent faculty positions have included Wright State University (Fellow Instructor 1986-1987), Ohio State University (1987-1990, including a year as Acting Division Director), and the long-term faculty position in the Dermatology Department at the Indiana University School of Medicine (1990-present). His current position is Theodore Arlook Professor of Clinical Dermatology and Professor of Clinical Dermatology.

Dr. Wolverton’s long-term academic interest has been systemic drug use in Dermatology, focusing on all aspects of Drug Safety, including a more recent focus in the complex area of Drug Interactions. He is best known for his series of four books concerning Dermatologic Drug Therapy: Systemic Drugs for Skin Diseases (published in 1991) and Comprehensive Dermatologic Drug Therapy (initially published in 2001, 2nd edition published in February 2007, with the 3rd edition of this title published late Fall 2012).

In addition, for 20 years he has been the Course Director for the Introduction to Cutaneous Biology course for Dermatology residents throughout the US and Canada that is sponsored by the Indiana University Department of Dermatology. 

He is a frequent visiting professor at various Dermatology residency programs, along with various state and local Dermatologic medical societies. He continues his strong interest in Dermatology resident education full-time at IU and during many of the visiting professorships.

Dermatology is the branch of medicine dealing with the skin, nails, hair and its diseases. It is a specialty with both medical and surgical aspects. A dermatologist treats diseases, in the widest sense, as well as some cosmetic problems of the skin, scalp, hair, and nails.

Recommended Articles

• Can Rosacea Affect my Eyes?

  Yes, rosacea does affect your eyes, and this condition is known as ocular rosacea. Rosacea is a chronic skin condition that frequently affects your cheeks, nose, and forehead. There are different types of rosacea. They are:...

• What are the Treatments for Hives (Urticaria)?

  Allergic skin disorders can be really disturbing. They can paralyze an individual’s quality of life and could even lead to tragic complications like allergic conditions. However, numerous treatments are available to control the symptoms efficiently.Types of Hives      ...

• Treatments for Heat Rash

  Heat rash, prickly heat, or miliaria is a condition of the skin that causes rash mostly because of excess sweating. It is a condition that occurs if the sweat ducts cannot efficiently excrete sweat from the body. As a result, sweat accumulates within the skin layers causing a rash that is...

• How Can Skin Grafting Treat Melanoma?

  What is melanoma?Melanoma is a type of skin cancer that affects the melanocytes or the skin cells that contain the pigment melanin. It is caused when long or repeated exposure to UV radiation damages the DNA of these skin cells and causes them to divide uncontrollably forming a malignant tumor....

• Heat Rash: What Is Miliaria Rubra?

  Heat rash is a skin condition that occurs when sweat ducts get blocked deeper below the skin surface. It mostly occurs when the weather conditions are hot and humid. The condition prevents the sweat produced from escaping and this leads to irritation of the skin.What is miliaria rubra?There are...

• How to Prevent Varicose Veins

  Although spider veins and varicose veins do not seem to bother the majority, they can lead to pain and can result in skin ulcers in severe cases. Although you cannot keep varicose veins away totally, there are certain things you can practice to lower the risk of developing them. Factors That...